Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Orders All Injectables Inspected In Wake Of Three Deaths

This article was originally published in PharmAsia News

Executive Summary

China's State FDA ordered its local bureaus around the country to inspect all intravenous injectables by the end of the year to ensure none is contaminated. The agency took the action in the wake of at least three incidents in which people died after receiving an injection with an herb produced by Wandashan Pharmaceutical, later found to be contaminated with bacteria. SFDA bureaus were instructed to determine how an injection was produced, its ingredients, equipment used and other information through quality spot-checks and risk evaluation. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts